Enbiotech Polandsp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2016-11-29
Share capital
100,000.00 PLN
Registered address
ul. Wojciecha Górskiego 6/73, 00-033 Warszawa, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
No financial statement for 2022 – the filing deadline has passed. 3 of 4 financial statements were filed late (the longest delay 1037 days for 2018).
- 2022not filed
- 202117/05/2022
- 202017/05/2022
- 201917/05/2022
- 201817/05/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Aldo Zamuner – President of the Management Board
Manner of representation
Each member of the management board may represent the company independently.
Supervisory board
Jacek Marcin Bieniak – Supervisory Board Member
Cosimo Manzo – Supervisory Board Member
Marcin Krzysztof Ernst – Supervisory Board Member
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Enbiotech Societaa Responsabilita Limitata | 595 | $8,036.20 | 29.75% |
Marcin Krzysztof Ernstage 54 | 1,400 | $18,908.70 | 70% |
Others | 5 | $67.53 | 0.25% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-11-30.
43 1090 1056 0000 0001 5060 7776
44 1090 1056 0000 0001 5060 7758
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fluence Technologysp. z o.o. | $2,486,673.06 | fluence.pl | ||
| Lymelab Pharma sp. z o.o.sp. k. | $424,756.39 | lymelabpharma.com | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com | ||
| IncellvuS.A. | $6,985.93 | incellvu.pl | ||
| Biorenomésp. z o.o. | – | biorenome.pl | ||
| Fatbrainsp. z o.o. | – | fatbrain.pl | ||
| SI Roboticssp. z o.o. | – | sirobotics.eu | ||
| Syn2bioS.A. | – | syn2bio.pl | ||
| Caslavinieri Advancements Interactivesp. z o.o. | – | caslavinieri.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-16 | Address change (Aleje Jerozolimskie 439, 05-800, Pruszków → Ul. Wojciecha Górskiego 6/73, 00-033, Warszawa) | |
| 2025-04-16 | Switch to PKD 2025 (5 PKD 2007 codes → 3 PKD 2025 codes) | |
| 2024-05-21 | Address change (Al. Aleje Jerozolimskie 439, 05-800, Warszawa → Aleje Jerozolimskie 439, 05-800, Pruszków) | |
| 2024-04-23 | Address change (Ul. Chmielna 73, 00-801, Warszawa → Al. Aleje Jerozolimskie 439, 05-800, Warszawa) | |
| 2022-11-15 | Address change (Ul. Marszałkowska 58, 00-545, Warszawa → Ul. Chmielna 73, 00-801, Warszawa) |
FAQ
The main business activity of Enbiotech Poland focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on November 29, 2016.
The headquarters is located at: ul. Wojciecha Górskiego 6, 00-033 Warszawa.
The share capital of the company is PLN 100,000 (approx. $27,012).
The latest available financial statement covers the period from January 1, 2021 to December 31, 2021.
Last updated: 2026-04-20